Skip to main content
Clinical Trials/NCT01283854
NCT01283854CompletedNot Applicable

Preventing Gestational Diabetes Mellitus Using a Home-based Supervised Exercise Program During Pregnancy

The University of Western Australia2 sites in 1 country172 target enrollmentStarted: June 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
172
Locations
2
Primary Endpoint
Diagnosis of gestational diabetes mellitus

Study Overview

Brief Summary

Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy and has serious health implications for both the pregnant woman and her child. In particular, offspring of mothers with GDM have an increased prevalence of obesity, diabetes and metabolic syndrome, perpetuating serious health consequences in subsequent generations.

Although regular exercise offers numerous benefits for both the mother and her child, its effectiveness in preventing GDM remains to be established. It has been recently shown that regular supervised home-based exercise may attenuate the decline in glucose tolerance in obese pregnant women. This study aims to conduct a single-centred, multi-sited, single-blinded randomised controlled trial examining the effect of 14 weeks of supervised home-based exercise (commenced at 14 weeks gestation) on the recurrence and severity of GDM, along with other aspects of maternal and fetal wellbeing.

Eligible participants (n = 200) will be randomly allocated to an exercise intervention (n = 100) or a control group (n = 100). The exercise intervention will involve three 60-minute home-based, supervised exercise sessions each week. This type of program overcomes many of the barriers to exercise in this population including transportation, child care issues and embarrassment associated with exercising in a public venue. The investigators have already shown this program to be both feasible and warmly accepted by obese pregnant women.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • women at 12-13 weeks gestation, with a history of gestational diabetes in a previous pregnancy.

Exclusion Criteria

  • unable to participate in the supervised 14 week home-based exercise program
  • less than 18 years of age
  • unable to understand the implications of participation in the trial
  • women with a multiple pregnancy
  • women with pre-existing diabetes (type 1 or 2) or cardiac disease
  • women currently engaged in a structured exercise program

Outcomes

Primary Outcomes

Diagnosis of gestational diabetes mellitus

Time Frame: After the 14 week intervention period (28 weeks gestation)

Secondary Outcomes

  • Insulin sensitivity and glucose tolerance(Pre and post-intervention (14 and 28 weeks of gestation))
  • Maternal aerobic fitness levels(Pre and post-intervention (14 and 28 weeks gestation))
  • Maternal morphology (girths and skinfold measures)(Pre and post-intervention (14 and 28 weeks gestation))
  • Maternal mental health(Pre and post-intervention (14 and 28 weeks gestation))
  • Obstetric outcomes (rates of medical intervention during labour, birth weight, newborn anthropometrics and incidence of newborn hypoglycemia)(At time of delivery (approximately 40 weeks gestation))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kym Guelfi

Assistant Professor Kym Guelfi

The University of Western Australia

Study Sites (2)

Loading locations...

Similar Trials

The Cycle Study: a Study of the... | Clinical Trial